Clarify Medical Announces Issuance of Patent for Smartphone-Connected Phototherapy System

Clarify Medical, a Serra Capital III portfolio company, made an exciting announcement recently that they have been issued an official patent for their phototherapy system to be connected via smartphone. The Clarify Medical® Home Light Therapy System is a software-controlled home phototherapy system for the treatment of psoriasis, vitiligo, eczema, and other skin conditions. The patent covers technology which enables patients to treat at home with controlled dosing protocols prescribed by physicians.

Source: https://www.businesswire.com/news/home/20180314005955/en/Clarify-Medical-Announces-Issuance-Patent-Smartphone-Connected-Phototherapy

Clarify Medical Announces National Launch of Home Light Therapy System for Psoriasis

Clarify Medical, a Serra Capital III portfolio company, recently announced the launch of its commercial product, the Home Light Therapy System. This FDA-cleared, home-based treatment technology for psoriasis and vitiligo is now rolling out for national distribution. 

Clarify brings handheld, guided therapy to millions of patients, while staying wirelessly connected to physicians and dermatologists. Clarify Medical improves care by bringing convenient, low-cost therapy into a patient’s home.

Source: http://www.businesswire.com/news/home/20171114006286/en/Clarify-Medical-Announces-National-Launch-Home-Light

Clarify Medical Announces Partnership With DermatologistOnCall

Clarify Medical, a Serra Capital III portfolio company, has partnered with DermatologistOnCall to to Innovate the Treatment of Chronic Skin Conditions. Clarify Medical  is a connected device that uses cutting edge LED technology to bring personal, private prescription phototherapy to patients with psoriasis, eczema and vitiligo.

“We are delighted to be working with DermatologistOnCall,” said Charlene Kakimoto MD, Clarify Medical’s Chief Medical Officer. “More than 25 percent of the patients we’ve engaged with do not have a dermatologist, and have asked for our help in finding one. DermatologistOnCall will provide an ideal response for this ongoing need, especially in areas of the country where office visits involve long wait or travel times. Together we have a fantastic opportunity to improve care for appropriate patients with chronic skin conditions. Our Clarify CarePartners, through the Clarify App, will help make sure that busy practices are diagnosing patients and managing their care, not dealing with questions about home phototherapy.”

Clarify Medical Publishes Form D for $5M Equity Financing

Clarify Medical, a Serra Capital III portfolio company, has just published a new filing - a Form D $5M Equity Financing. Clarify Medical is a connected device that uses cutting edge LED technology to bring personal, private prescription phototherapy to patients with psoriasis, eczema and vitiligo. Clarify brings handheld, guided therapy to millions of patients, while staying wirelessly connected to physicians and dermatologists. Clarify Medical improves care by bringing convenient, low-cost therapy into a patient’s home.

For more information on Form D's and what they are used for, and to learn more about Clarify Medical, follow the link below. 

Source: http://presstelegraph.com/clarify-medical-5-00-million-fundraising-james-m-sweeney-published-jul-20-filing/

Clarify Medical Receives FDA Clearance

Clarify Medical, a Serra Capital III portfolio company, has received FDA clearance for its main technology - The Clarify Medical Phototherapy System, which is the core technology of its Clarify Home Light Therapy service. Clarify’s proprietary technology allows patients with chronic skin diseases to receive UVB phototherapy in their homes, linked to their physicians and to Clarify support services through their smartphones. The company plans to start offering the technology in November of 2017.

“This is a major milestone,” said James M. Sweeney, Clarify Medical’s CEO. “We look forward to offering Clarify Home Light Therapy to patients throughout the country, beginning in November. It offers an in-office therapy proven effective with skin diseases such as psoriasis, vitiligo, and eczema in a convenient form.”

Source: http://www.businesswire.com/news/home/20170606005075/en/Clarify-Medical-Core-Technology-Receives-FDA-Clearance

Skylit Medical Changes Name to Clarify Medical, Appoints New CEO

Skylit Medical, a Serra Capital III portfolio company, announced on September 15 that they had changed their name to Clarify Medical, and also appointed new CEO James Sweeney. 

Clarify Medical is a private company making a hand-held UVB light device that can be used to treat skin conditions like psoriasis, eczema and vitiligo. The mobility of the device allows patients to treat their conditions at home instead of visiting doctors or clinics, while allowing physicians to treat skin conditions without dedicating office space or labor hours for phototherapy.

Source: http://sdbj.com/news/2016/sep/15/skylit-medical-changes-name-clarify-medical-appoin/